Recently, we showed that overexpression of C1QA in ER-negative basal-like breast cancer patients, which have the poorest prognosis (Sorlie et al, 2001), is associated with better outcome (Teschendorff et al, 2006, 2007; Teschendorff and Caldas, 2008). Here, C1QA is linked to breast cancer.